Treatment Related Risk, Benefit, and Access in Functional GI and Motility Disorders
The process of drug development, review, delivery, and use is one that involves many stakeholders, including industries, regulators, physicians, and patients. All play roles that influence treatment outcomes. The illness experiences and perceptions of patients are key components to understanding a disease and providing safe and effective treatments. Looking at the experience of the IBS community with the drug alosetron as an example, this article reflects upon how treatment delivery can break down, and actions that can help ensure that safer, effective, treatments are made available to patients in need.